EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Facioscapulohumeral Muscular Dystrophy: Clinical, Therapeutic and Regulatory Updates
Editorial Archive

Facioscapulohumeral Muscular Dystrophy: Clinical, Therapeutic and Regulatory Updates

Facioscapulohumeral muscular dystrophy (MD), commonly known as FSHD or FSH, is a complex, inheritable muscle disease with an etiology that is rapidly becoming more el...
Continue Reading →
Oncology – A Bouquet of Rare and Ultra-rare Diseases
Editorial Archive

Oncology – A Bouquet of Rare and Ultra-rare Diseases

Oncology clinical trials are widely recognised as being amongst the most complex trials to design, set up, and deliver. Whilst there is good progress in finding optim...
Continue Reading →
Recent Trends and Innovations in Outcomes and Design of Clinical Trials in Respiratory Drug Development – Part 1: Outcomes
Editorial Archive

Recent Trends and Innovations in Outcomes and Design of Clinical Trials in Respiratory Drug Development – Part 1: Outcomes

In this paper, Robert Lins, MD, PhD, Respiratory Project Director at SGS, illustrates how respiratory drug development has, for years, been relying on the administrat...
Continue Reading →
FDA Marks Milestone in Patient-Focused Drug Development
Editorial Archive

FDA Marks Milestone in Patient-Focused Drug Development

In this Watch Pages item, Molly Fellin Spence, a medical and regulatory writer for the Cortellis database and AdComm Bulletin at Clarivate Analytics, discusses how th...
Continue Reading →
Catalyst: 12th January 2026
Quotient